Last 12 months
Inside the activity.
17 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 11 | 0 |
| Dec 2025 | 2 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 1 | 0 |
| May 2026 | 3 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| November 20, 2023 Filed Nov 22, 2023 21:21 UTC Amendment |
Hagopian Henry IIIChief Financial Officer
|
GrantCommon Stock | 820 | $6.10 | $5,002.00 |
DisclosureSEC source: 0001104659-23-120760 · tm2331305d8_4a.xml · nonDerivative · entry 1 Hagopian Henry III · CIK 0001821822 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,820 Read SEC document |
| November 17, 2023 Filed Jul 3, 2024 21:18 UTC |
White Mark K.Director
|
GrantStock Option (right to buy) · Derivative | 26,200 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001104659-24-077836 · tm2417696-5_4seq1.xml · derivative · entry 1 White Mark K. · CIK 0001786183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,200 Underlying: Common Stock · 26,200 shares Expires 2033-11-17 F1 · security: On June 12, 2024, stockholders of Annovis Bio, Inc. ("the Company") approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved. F2 · derivative.exercise_date: The stock option shall vest immediately upon grant date. Read SEC document |
| November 17, 2023 Filed Jul 3, 2024 21:17 UTC |
McCarthy ReidDirector
|
GrantStock Option (right to buy) · Derivative | 29,600 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001104659-24-077835 · tm2417696-4_4seq1.xml · derivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,600 Underlying: Common Stock · 29,600 shares Expires 2033-11-17 F1 · security: On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved. F2 · derivative.exercise_date: The stock option shall vest immediately upon grant date. Read SEC document |
| November 17, 2023 Filed Jul 3, 2024 21:16 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
GrantStock Option (right to buy) · Derivative | 108,800 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001104659-24-077834 · tm2417696-3_4seq1.xml · derivative · entry 5 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 108,800 Underlying: Common Stock · 108,800 shares Expires 2033-11-17 F4 · security: The stock option was granted in lieu of cash payment for 2023 fiscal year bonus. 100% of the stock option grant listed was also contingent upon the aforementioned amendment to the 2019 Equity Incentive Plan to increase the number of issuable shares from 2,000,000 to 3,000,000. It would have been forfeited if the amendment had not been approved. F5 · derivative.exercise_date: The stock option shall vest immediately. Read SEC document |
| November 17, 2023 Filed Jul 3, 2024 21:16 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
GrantStock Option (right to buy) · Derivative | 252,000 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001104659-24-077834 · tm2417696-3_4seq1.xml · derivative · entry 4 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 252,000 Underlying: Common Stock · 252,000 shares Expires 2033-11-17 F2 · security: On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved. F3 · derivative.exercise_date: Stock option will vest in eight consecutive quarterly installments of 31,500 shares each on the 17th day of February, May, August and November of each year, continuing through November 17, 2025. Read SEC document |
| November 17, 2023 Filed Jul 3, 2024 21:16 UTC |
Hoffman Michael BDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 29,600 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001104659-24-077833 · tm2417696-2_4seq1.xml · derivative · entry 1 Hoffman Michael B · CIK 0001290208 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,600 Underlying: Common Stock · 29,600 shares Expires 2033-11-17 F1 · security: On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved. F2 · derivative.exercise_date: The stock option shall vest immediately upon grant date. Read SEC document |
| November 17, 2023 Filed Jul 3, 2024 21:15 UTC |
Bruck ClaudineDirector
|
GrantStock Option (right to buy) · Derivative | 26,200 | $0.00 Strike: $6.07 | $0.00 |
DisclosureSEC source: 0001104659-24-077831 · tm2417696-1_4seq1.xml · derivative · entry 1 Bruck Claudine · CIK 0001733680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,200 Underlying: Common Stock · 26,200 shares Expires 2033-11-17 F1 · security: On June 12, 2024, stockholders of Annovis Bio, Inc. approved an amendment to the 2019 Equity Incentive Plan to increase the number of shares issuable thereunder from 2,000,000 to 3,000,000. 50% of the stock option grant listed was contingent upon the approval of such amendment and would have been forfeited if the amendment had not been approved. F2 · derivative.exercise_date: The stock option shall vest immediately upon grant date. Read SEC document |
| April 24, 2023 Filed Apr 26, 2023 20:34 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
GiftCommon Stock | 3,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-23-050393 · tm2313853-1_4seq1.xml · nonDerivative · entry 1 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,057,489 Read SEC document |
| April 07, 2023 Filed Apr 12, 2023 01:14 UTC |
White Mark K.Director
|
GrantCommon Stock | 3,000 | $12.61 | $37,830.00 |
DisclosureSEC source: 0001104659-23-044209 · tm2312464-6_4seq1.xml · nonDerivative · entry 1 White Mark K. · CIK 0001786183 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,177 Read SEC document |
| April 07, 2023 Filed Apr 12, 2023 01:11 UTC |
Bruck ClaudineDirector
|
GrantCommon Stock | 500 | $12.61 | $6,305.00 |
DisclosureSEC source: 0001104659-23-044208 · tm2312464-5_4seq1.xml · nonDerivative · entry 1 Bruck Claudine · CIK 0001733680 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,567 Read SEC document |
| April 07, 2023 Filed Apr 12, 2023 01:08 UTC |
Hagopian Henry IIIChief Financial Officer
|
GrantCommon Stock | 1,000 | $12.61 | $12,610.00 |
DisclosureSEC source: 0001104659-23-044206 · tm2312464-4_4seq.xml · nonDerivative · entry 1 Hagopian Henry III · CIK 0001821822 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,000 Read SEC document |
| April 07, 2023 Filed Apr 12, 2023 01:06 UTC |
Hoffman Michael BDirector · 10% owner
|
GrantCommon Stock | 59,477 | $12.61 | $750,004.97 |
DisclosureSEC source: 0001104659-23-044204 · tm2312464-3_4seq1.xml · nonDerivative · entry 1 Hoffman Michael B · CIK 0001290208 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Indirect · The 2018 Jane and Michael Hoffman Descendants Trust Disclosed balance after: 59,477 F1 · ownership.nature: The shares are held in a family trust formed by the reporting person and the reporting person has voting and investment power over such shares. Read SEC document |
| April 07, 2023 Filed Apr 12, 2023 01:05 UTC |
McCarthy ReidDirector
|
GrantCommon Stock | 476 | $12.61 | $6,002.36 |
DisclosureSEC source: 0001104659-23-044203 · tm2312464-2_4seq1.xml · nonDerivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,305 Read SEC document |
| April 07, 2023 Filed Apr 12, 2023 01:03 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
GrantCommon Stock | 20,000 | $12.61 | $252,200.00 |
DisclosureSEC source: 0001104659-23-044202 · tm2312464-1_4seq1.xml · nonDerivative · entry 1 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,060,489 Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 22:11 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 52,755 | $0.00 Strike: $0.14 | $0.00 |
DisclosureSEC source: 0001104659-23-014610 · tm231947-2_4seq1.xml · derivative · entry 2 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 52,755 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All of the shares underlying the option are fully vested and exercisable. Read SEC document |
| February 06, 2023 Filed Feb 8, 2023 22:11 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
Exercise / conversionCommon Stock | 52,755 | $0.14 | $7,385.70 |
DisclosureSEC source: 0001104659-23-014610 · tm231947-2_4seq1.xml · nonDerivative · entry 1 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,040,489 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:38 UTC |
Hoffman Michael BDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 6,820 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001104659-23-005476 · tm234043-2_4seq1.xml · derivative · entry 1 Hoffman Michael B · CIK 0001290208 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,820 Underlying: Common Stock · 6,820 shares Expires 2033-01-18 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:37 UTC |
Bruck ClaudineDirector
|
GrantStock Option (right to buy) · Derivative | 5,967 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001104659-23-005475 · tm234043-1_4seq1.xml · derivative · entry 1 Bruck Claudine · CIK 0001733680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,967 Underlying: Common Stock · 5,967 shares Expires 2033-01-18 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:43 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
GrantStock Option (right to buy) · Derivative | 21,312 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001104659-23-005481 · tm234043-6_4seq1.xml · derivative · entry 1 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 21,312 Underlying: Common Stock · 21,312 shares Expires 2033-01-18 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive quarterly installments of 2,664 shares each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:42 UTC |
Hagopian Henry IIIChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 7,672 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001104659-23-005480 · tm234043-5_4seq1.xml · derivative · entry 1 Hagopian Henry III · CIK 0001821822 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,672 Underlying: Common Stock · 7,672 shares Expires 2033-01-18 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive quarterly installments of 1,918 shares each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:40 UTC |
White Mark K.Director
|
GrantStock Option (right to buy) · Derivative | 5,967 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001104659-23-005478 · tm234043-4_4seq1.xml · derivative · entry 1 White Mark K. · CIK 0001786183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,967 Underlying: Common Stock · 5,967 shares Expires 2033-01-18 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025. Read SEC document |
| January 18, 2023 Filed Jan 20, 2023 22:39 UTC |
McCarthy ReidDirector
|
GrantStock Option (right to buy) · Derivative | 5,967 | $0.00 Strike: $13.17 | $0.00 |
DisclosureSEC source: 0001104659-23-005477 · tm234043-3_4seq1.xml · derivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,967 Underlying: Common Stock · 5,967 shares Expires 2033-01-18 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive equal quarterly installments each on the 18th day of April, July, October and January of each year, commencing April 18, 2023, and continuing through January 18, 2025. Read SEC document |
| August 29, 2022 Filed Sep 1, 2022 00:14 UTC |
Hagopian Henry IIIChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 120,000 | $0.00 Strike: $11.55 | $0.00 |
DisclosureSEC source: 0001104659-22-096653 · tm2224852-2_4seq1.xml · derivative · entry 1 Hagopian Henry III · CIK 0001821822 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 120,000 Underlying: Common Stock · 120,000 shares Expires 2032-08-29 F1 · derivative.exercise_date: The stock option vests one-third on August 29, 2023 and the remaining two-thirds will vest in eight consecutive quarterly installments beginning the fifteenth month after August 29, 2022, and will vest in full upon a Change of Control (as defined in the Company's 2019 Equity Incentive Plan), with vesting conditioned on continued employment on the applicable vesting dates. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 02:08 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 32,959 | $0.00 Strike: $0.14 | $0.00 |
DisclosureSEC source: 0001104659-22-005059 · tm221949-7_4seq1.xml · derivative · entry 2 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 52,755 Underlying: Common Stock · 32,959 shares Expires 2027-04-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_date: All of the shares underlying the option are fully vested and exercisable. Read SEC document |
| January 14, 2022 Filed Jan 19, 2022 02:08 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
Exercise / conversionCommon Stock | 32,959 | $0.14 | $4,614.26 |
DisclosureSEC source: 0001104659-22-005059 · tm221949-7_4seq1.xml · nonDerivative · entry 1 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 987,734 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 00:41 UTC |
Hoffman Michael BDirector · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 7,142 | $0.00 Strike: $0.25 | $0.00 |
DisclosureSEC source: 0001104659-22-001638 · tm221949-2_4seq1.xml · derivative · entry 7 Hoffman Michael B · CIK 0001290208 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 7,142 shares Expires 2028-04-06 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 00:41 UTC |
Hoffman Michael BDirector · 10% owner
|
Exercise / conversionStock Option (right to buy) · Derivative | 30,000 | $0.00 Strike: $4.39 | $0.00 |
DisclosureSEC source: 0001104659-22-001638 · tm221949-2_4seq1.xml · derivative · entry 6 Hoffman Michael B · CIK 0001290208 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 30,000 shares Expires 2030-07-01 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 00:41 UTC |
Hoffman Michael BDirector · 10% owner
|
Tax withholdingCommon Stock | 90 | $19.78 | $1,780.20 |
DisclosureSEC source: 0001104659-22-001638 · tm221949-2_4seq1.xml · nonDerivative · entry 4 Hoffman Michael B · CIK 0001290208 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,416,283 F2 · shares: Reflects 90 shares withheld by issuer at the market price of $19.78 per share less an exercise price of $0.25 per share to fund the cashless exercise of 7,142 options. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 00:41 UTC |
Hoffman Michael BDirector · 10% owner
|
Exercise / conversionCommon Stock | 7,142 | $0.25 | $1,785.50 |
DisclosureSEC source: 0001104659-22-001638 · tm221949-2_4seq1.xml · nonDerivative · entry 3 Hoffman Michael B · CIK 0001290208 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,416,373 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 00:41 UTC |
Hoffman Michael BDirector · 10% owner
|
Tax withholdingCommon Stock | 6,658 | $19.78 | $131,695.24 |
DisclosureSEC source: 0001104659-22-001638 · tm221949-2_4seq1.xml · nonDerivative · entry 2 Hoffman Michael B · CIK 0001290208 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,409,231 F1 · shares: Reflects 6,658 shares withheld by issuer at the market price of $19.78 per share less an exercise price of $4.39 per share to fund the cashless exercise of 30,000 options. Read SEC document |
| January 04, 2022 Filed Jan 6, 2022 00:41 UTC |
Hoffman Michael BDirector · 10% owner
|
Exercise / conversionCommon Stock | 30,000 | $4.39 | $131,700.00 |
DisclosureSEC source: 0001104659-22-001638 · tm221949-2_4seq1.xml · nonDerivative · entry 1 Hoffman Michael B · CIK 0001290208 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,415,889 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:44 UTC |
White Mark K.Director
|
GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $19.78 | $0.00 |
DisclosureSEC source: 0001104659-22-001644 · tm221949-6_4seq1.xml · derivative · entry 1 White Mark K. · CIK 0001786183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2032-01-03 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive quarterly installments of 1,000 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:43 UTC |
McGroarty Jeffrey BrianChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 28,000 | $0.00 Strike: $19.78 | $0.00 |
DisclosureSEC source: 0001104659-22-001643 · tm221949-5_4seq1.xml · derivative · entry 1 McGroarty Jeffrey Brian · CIK 0001563273 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,000 Underlying: Common Stock · 28,000 shares Expires 2032-01-03 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive quarterly installments of 3,500 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:42 UTC |
McCarthy ReidDirector
|
GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $19.78 | $0.00 |
DisclosureSEC source: 0001104659-22-001642 · tm221949-4_4seq1.xml · derivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2032-01-03 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive quarterly installments of 1,000 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:42 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
GrantStock Option (right to buy) · Derivative | 19,894 | $0.00 Strike: $19.78 | $0.00 |
DisclosureSEC source: 0001104659-22-001640 · tm221949-3_4seq1.xml · derivative · entry 2 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,894 Underlying: Common Stock · 19,894 shares Expires 2032-01-03 F2 · derivative.exercise_date: The stock option shall vest and become exercisable in two equal installments of 9,947 shares on March 31, 2022 and March 31, 2023. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:42 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
GrantStock Option (right to buy) · Derivative | 83,400 | $0.00 Strike: $19.78 | $0.00 |
DisclosureSEC source: 0001104659-22-001640 · tm221949-3_4seq1.xml · derivative · entry 1 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 83,400 Underlying: Common Stock · 83,400 shares Expires 2032-01-03 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive quarterly installments of 10,425 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:41 UTC |
Hoffman Michael BDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 9,000 | $0.00 Strike: $19.78 | $0.00 |
DisclosureSEC source: 0001104659-22-001638 · tm221949-2_4seq1.xml · derivative · entry 5 Hoffman Michael B · CIK 0001290208 · Director · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,000 Underlying: Common Stock · 9,000 shares Expires 2032-01-03 F3 · derivative.exercise_date: The stock option shall vest in eight consecutive quarterly installments of 1,125 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024. Read SEC document |
| January 03, 2022 Filed Jan 6, 2022 00:40 UTC |
Bruck ClaudineDirector
|
GrantStock Option (right to buy) · Derivative | 8,000 | $0.00 Strike: $19.78 | $0.00 |
DisclosureSEC source: 0001104659-22-001637 · tm221949-1_4seq1.xml · derivative · entry 1 Bruck Claudine · CIK 0001733680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,000 Underlying: Common Stock · 8,000 shares Expires 2032-01-03 F1 · derivative.exercise_date: The stock option shall vest in eight consecutive quarterly installments of 1,000 shares each on the 3rd day of April, July, October and January of each year, commencing April 3, 2022, and continuing through January 3, 2024. Read SEC document |
| December 20, 2021 Filed Jan 19, 2022 02:07 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
GiftCommon Stock | 20,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-22-005057 · tm221949-8_5seq1.xml · nonDerivative · entry 5 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 954,775 F2 · shares: Charitable gift. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 22:01 UTC |
McGroarty Jeffrey BrianChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 165,199 | $0.00 Strike: $20.97 | $0.00 |
DisclosureSEC source: 0001104659-21-147676 · tm2134914d2_4seq1.xml · derivative · entry 2 McGroarty Jeffrey Brian · CIK 0001563273 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 165,199 Underlying: Common Stock · 165,199 shares Expires 2031-12-06 F2 · derivative.exercise_date: The stock option shall vest in two installments: (i) the first installment of 82,600 shares on March 31, 2022 and (ii) a second and final installment of 82,599 shares on March 31, 2023, provided that the reporting person continues to be employed by the issuer on the applicable vesting date. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 22:01 UTC |
McGroarty Jeffrey BrianChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 30,396 | $0.00 Strike: $20.97 | $0.00 |
DisclosureSEC source: 0001104659-21-147676 · tm2134914d2_4seq1.xml · derivative · entry 1 McGroarty Jeffrey Brian · CIK 0001563273 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,396 Underlying: Common Stock · 30,396 shares Expires 2031-12-06 F1 · derivative.exercise_date: The stock option is 100% vested. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 22:00 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
GrantStock Option (right to buy) · Derivative | 145,305 | $0.00 Strike: $20.97 | $0.00 |
DisclosureSEC source: 0001104659-21-147673 · tm2134914-1_4seq1.xml · derivative · entry 2 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 145,305 Underlying: Common Stock · 145,305 shares Expires 2031-12-06 F2 · derivative.exercise_date: The stock option shall vest in two installments: (i) the first installment of 72,653 shares on March 31, 2022 and (ii) a second and final installment of 72,652 shares on March 31, 2023, provided that the reporting person continues to be employed by the issuer on the applicable vesting date. Read SEC document |
| December 06, 2021 Filed Dec 8, 2021 22:00 UTC |
Maccecchini Maria-LuisaDirector · President and CEO · 10% owner
|
GrantStock Option (right to buy) · Derivative | 112,995 | $0.00 Strike: $20.97 | $0.00 |
DisclosureSEC source: 0001104659-21-147673 · tm2134914-1_4seq1.xml · derivative · entry 1 Maccecchini Maria-Luisa · CIK 0001315018 · Director · President and CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 112,995 Underlying: Common Stock · 112,995 shares Expires 2031-12-06 F1 · derivative.exercise_date: The stock option is 100% vested. Read SEC document |
| October 12, 2021 Filed Oct 13, 2021 20:02 UTC |
White Mark K.Director
|
PurchaseCommon Stock | 5,000 | $27.40 | $137,000.00 |
DisclosureSEC source: 0001415889-21-004863 · form4-10132021_011054.xml · nonDerivative · entry 1 White Mark K. · CIK 0001786183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 56,177 F1 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $27.25 to $27.55, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 20:03 UTC |
Bruck ClaudineDirector
|
PurchaseCommon Stock | 181 | $27.66 | $5,006.46 |
DisclosureSEC source: 0001415889-21-004864 · form4-10132021_011056.xml · nonDerivative · entry 1 Bruck Claudine · CIK 0001733680 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,067 Read SEC document |
| October 11, 2021 Filed Oct 13, 2021 20:00 UTC |
Maccecchini Maria-LuisaDirector · PRESIDENT AND CEO · 10% owner
|
PurchaseCommon Stock | 18,000 | $27.61 | $496,980.00 |
DisclosureSEC source: 0001415889-21-004862 · form4-10132021_011036.xml · nonDerivative · entry 1 Maccecchini Maria-Luisa · CIK 0001315018 · Director · PRESIDENT AND CEO · 10% owner 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 976,775 F1 · price: The price represents the weighted average purchase price for multiple transactions reported on this line. The prices of the transactions ranged from $27.58 to $27.64, inclusive. Upon request of the SEC staff or the issuer, the reporting person will provide full information regarding the number of shares purchased at each separate price. Read SEC document |
| August 19, 2021 Filed Aug 23, 2021 15:36 UTC |
McCarthy ReidDirector
|
PurchaseCommon Stock, $0.0001 par value | 500 | $37.61 | $18,805.00 |
DisclosureSEC source: 0001104659-21-108434 · tm2125684d1_4seq1.xml · nonDerivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,829 Read SEC document |
| July 07, 2021 Filed Jul 9, 2021 22:28 UTC |
White Mark K.Director
|
GrantStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $102.85 | $0.00 |
DisclosureSEC source: 0001104659-21-090746 · tm2121908-6_4seq1.xml · derivative · entry 1 White Mark K. · CIK 0001786183 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2031-07-07 F1 · derivative.exercise_date: The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to serve as a director of the issuer on the applicable vesting date. Read SEC document |
| July 07, 2021 Filed Jul 9, 2021 22:28 UTC |
McGroarty Jeffrey BrianChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 14,000 | $0.00 Strike: $102.85 | $0.00 |
DisclosureSEC source: 0001104659-21-090745 · tm2121908-5_4seq1.xml · derivative · entry 1 McGroarty Jeffrey Brian · CIK 0001563273 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,000 Underlying: Common Stock · 14,000 shares Expires 2031-07-07 F1 · derivative.exercise_date: The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to be employed by the issuer on the applicable vesting date. Read SEC document |
| July 07, 2021 Filed Jul 9, 2021 22:27 UTC |
McCarthy ReidDirector
|
GrantStock Option (right to buy) · Derivative | 4,000 | $0.00 Strike: $102.85 | $0.00 |
DisclosureSEC source: 0001104659-21-090744 · tm2121908-4_4seq1.xml · derivative · entry 1 McCarthy Reid · CIK 0001857733 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 Underlying: Common Stock · 4,000 shares Expires 2031-07-07 F1 · derivative.exercise_date: The stock option shall vest in eight substantially equal quarterly installments beginning October 7, 2021, provided that the reporting person continues to serve as a director of the issuer on the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.